CIK: 1225503 - Address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA 02472
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret213-20-3-20-30-43-19
S%wins6767671006710078

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/16/22 16:15
8/12/22
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-85585.490-10-626D
3/22/22 17:52
3/21/22
ENTAEnanta Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsCarter Bruce L AMADS.d-40767.830-6-1000D
4/6/21 20:06
4/5/21
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-399177.110-2-393D
2/3/21 17:08
2/2/21
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-430191.120-2-393D
12/16/20 17:37
12/14/20
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-554246.280-2-532D
8/13/20 16:03
8/11/20
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-284126.410-2-532D
5/20/20 17:10
5/18/20
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-427106.860-4-672D
11/22/19 16:46
11/20/19
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-28494.740-3-1000D
8/23/19 18:01
8/21/19
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-26889.240-3-1000D
5/24/19 17:00
5/22/19
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-22675.200-3-1000D
3/12/19 16:51
3/11/19
ENTAEnanta Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsCarter Bruce L AMADS.d-15399.160-2-1000D
2/22/19 19:00
2/20/19
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-22173.640-3-1000D
2/13/19 20:50
2/11/19
ENTAEnanta Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsCarter Bruce L AMADS.dm-69690.010-8-1000D
6/16/17 16:58
6/14/17
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS-41220.610-20-2949D
6/6/17 18:33
6/2/17
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS-5222.000-2-369D
5/31/17 21:27
5/26/17
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-27522.190-12-1571D
8/15/16 19:50
8/15/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-7722.675-3-347D125159789182052-5-6-5-32
6/15/15 18:35
6/15/15
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-19219.215-10-1000D69713333132-3-2617-21-32-32
4/14/15 17:12
4/13/15
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsCarter Bruce L ACADS.d-35317.6610-20-1000D159125169-9-5-11-210-22-35-59-53
8/25/06 17:32
8/24/06
ZGENZymogenetics IncWAHealthBioPrdBiological Products, (No DiagCarter Bruce L AWAOP,CEOS.d-50120.040-25-16131D
3/15/06 11:33
3/13/06
ZGENZymogenetics IncWAHealthBioPrdBiological Products, (No DiagCarter Bruce L AWADOP,CEOS.d-54421.750-25-16131
1/11/06 16:29
1/9/06
ZGENZymogenetics IncWAHealthBioPrdBiological Products, (No DiagCarter Bruce L AWADOP,CEOS.d-49819.920-25-16131
1/9/06 15:14
1/5/06
ZGENZymogenetics IncWAHealthBioPrdBiological Products, (No DiagCarter Bruce L AWADOP,CEOS.d-45018.000-25-16131
5/18/05 15:55
5/17/05
ZGENZymogenetics IncWAHealthBioPrdBiological Products, (No DiagCarter Bruce L AWADOP,CEOS.d-45018.000-25-16131D
2/16/05 12:30
2/14/05
ZGENZymogenetics IncWAHealthBioPrdBiological Products, (No DiagCarter Bruce L AWADOP,CEOS.d-48919.560-25-16131D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact